Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:43 am Sale | 2023-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital, LP | 2,284,372 5.340% | -372,529![]() (-14.02%) | Filing History |
| 2024-02-13 10:56 am Purchase | 2023-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Janus Henderson Group Ltd. JHG | 3,093,296 7.200% | 1,627,029![]() (+110.96%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BlackRock Inc. BLK | 3,464,587 8.100% | 955,955![]() (+38.11%) | Filing History |
| 2024-01-08 4:15 pm Sale | 2024-01-04 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 4,247,914 9.900% | -540,000![]() (-11.28%) | Filing History |
| 2024-01-08 4:05 pm Purchase | 2023-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 4,787,914 11.200% | 850,000![]() (+21.59%) | Filing History |
| 2023-06-05 4:31 pm Purchase | 2023-05-25 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA CAPITAL MANAGEMENT L.P. | 2,789,721 6.700% | 2,789,721![]() (New Position) | Filing History |
| 2023-05-15 4:17 pm Purchase | 2023-05-05 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Venrock Healthcare Capital Partners III, L.P. | 2,887,517 8.700% | 2,887,517![]() (New Position) | Filing History |
| 2023-02-14 08:32 am Purchase | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital, LP | 2,656,901 8.200% | 756,901![]() (+39.84%) | Filing History |
| 2023-02-09 09:07 am Sale | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Janus Henderson Group Ltd. JHG | 1,466,267 4.500% | -181,656![]() (-11.02%) | Filing History |
| 2023-02-08 4:15 pm Sale | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Kirn David | 2,022,498 6.200% | -11,877![]() (-0.58%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BlackRock Inc. BLK | 2,508,632 7.700% | 420,950![]() (+20.16%) | Filing History |
| 2022-06-21 4:53 pm Purchase | 2022-06-16 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,007,413 12.400% | 2,001,551![]() (+99.79%) | Filing History |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 3,937,914 12.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:33 pm Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Kirn David | 2,034,375 6.300% | 34,375![]() (+1.72%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | SCHAFFER DAVID | 901,215 2.800% | -1,098,785![]() (-54.94%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital, LP | 1,900,000 5.910% | 100,000![]() (+5.56%) | Filing History |
| 2022-02-11 3:54 pm Sale | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | PFIZER INC PFE | 341,658 1.060% | -1,325,000![]() (-79.50%) | Filing History |
| 2022-02-11 3:19 pm Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Janus Henderson Group Ltd. JHG | 1,647,923 5.100% | 1,647,923![]() (New Position) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | FMR LLC | 1,140,174 3.547% | -454,181![]() (-28.49%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BlackRock Inc. BLK | 2,087,682 6.500% | 2,087,682![]() (New Position) | Filing History |

